Gastrointestinal Stromal Tumor (GIST)

FDA Approves Treatment for Gastrointestinal Stromal Tumors

The US Food and Drug Administration (FDA) Monday approved the use of Stivarga (regorafenib) to treat certain advanced gastrointestinal stromal tumors (GISTs).